GVK Biosciences Appoints Dr. John Ellingboe as Senior Vice President, Discovery Chemistry

Hyderabad: Hyderabad-based contract research organisation GVK Biosciences today said that it had appointed Dr. John Ellingboe as senior vice president, discovery chemistry.

Dr. Ellingboe will report to Manni Kantipudi, president, GVK Biosciences, with responsibilities including the identification of leads and development candidates across multiple therapeutic areas and leading a department across several research sites.

Prior to joining GVK BIO, Dr. Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive background in medicinal chemistry and drug discovery and has worked in all phases of drug discovery. 

During the course of his time at Wyeth, he established a core parallel synthesis group, a lead identification group, and an integrated medicinal chemistry group that worked closely with screening sciences, computational chemistry, X-ray crystallography, and drug safety and metabolism groups to identify optimal development candidates.

While at Wyeth, he initiated and managed a large chemistry partnership with GVK BIO. Dr. Ellingboe received his undergraduate degree in Chemistry from Reed College and a Ph.D. in Organic Chemistry from MIT. He has over 150 publications, presentations and patents to his name.